Vancomycin, classified under HS code 30042096, is subject to varying tariff treatments across key importing countries.
United States: The U.S. maintains a Most Favored Nation (MFN) tariff rate of 0% for products under HS code 30042096. Additionally, under the U.S.-Australia Free Trade Agreement (FTA), preferential rates are applied to imports from Australia. However, specific tariff rates can vary based on product classification and trade agreements.
Germany: As a member of the European Union, Germany applies the EU's Common External Tariff. Medicaments containing antibiotics under HS code 30042096 generally attract an MFN tariff rate of 0%. The EU has FTAs with various countries, but specific preferential rates for imports from India would depend on the terms of any existing agreements.
Australia: Australia's MFN tariff rate for HS code 30042096 is 0%. Under the India-Australia Economic Cooperation and Trade Agreement (ECTA), preferential rates may apply to imports from India, potentially reducing tariffs further.
Saudi Arabia: Saudi Arabia imposes an MFN tariff rate of 0% on products under HS code 30042096. While Saudi Arabia is a member of the Gulf Cooperation Council (GCC), which has FTAs with certain countries, there is no specific FTA between Saudi Arabia and India affecting this product category.
Ethiopia: Ethiopia's MFN tariff rates for pharmaceuticals can vary. However, as a Least Developed Country (LDC), Ethiopia benefits from preferential trade terms under initiatives like the Generalized System of Preferences (GSP), which may offer reduced or zero tariffs on essential medicines.
Denmark: As part of the EU, Denmark applies the EU's Common External Tariff, with an MFN rate of 0% for HS code 30042096. Preferential rates for imports from India would depend on any existing EU-India trade agreements.
